New emerging data has made us rethink the power of vaccines in oncology. Why have we failed in the past, and how can we succeed in the future? By deciphering the challenges of immune suppression, resistance patterns and the tumour microenvironment, the Next Generation Cancer Vaccine Development Summit will explore emerging vaccine technologies and combination therapies to ensure the future clinical success of your cancer vaccines.

The Next Generation Cancer Vaccine Development Summit will unite over 100 senior scientists and oncology specialists who are committed to finding better antigens, more effective vectors, reassessing target patient populations and exploring new platforms with clinical data where CD8 immune responses have been documented to be strong and long lasting.